Morningstar Investment Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $394K | Sell |
2,616
-2,300
| -47% | -$346K | 0.07% | 124 |
|
|
2024
Q4 | $907K | Sell |
4,916
-58,744
| -92% | -$10.8M | 0.08% | 115 |
|
|
2024
Q3 | $12.6M | Buy |
63,660
+352
| +0.6% | +$69.8K | 0.13% | 119 |
|
|
2024
Q2 | $13.1M | Sell |
63,308
-561
| -0.9% | -$116K | 0.14% | 116 |
|
|
2024
Q1 | $17.2M | Sell |
63,869
-38,757
| -38% | -$10.4M | 0.19% | 106 |
|
|
2023
Q4 | $24.5M | Buy |
102,626
+51,110
| +99% | +$12.2M | 0.14% | 116 |
|
|
2023
Q3 | $10.1M | Buy |
51,516
+1,148
| +2% | +$224K | 0.13% | 118 |
|
|
2023
Q2 | $10.5M | Buy |
50,368
+43,112
| +594% | +$8.98M | 0.14% | 118 |
|
|
2023
Q1 | $1.44M | Buy |
7,256
+601
| +9% | +$119K | 0.02% | 161 |
|
|
2022
Q4 | $1.47M | Buy |
6,655
+220
| +3% | +$48.5K | 0.02% | 152 |
|
|
2022
Q3 | $1.35M | Buy |
+6,435
| New | +$1.35M | 0.02% | 150 |
|
|
2014
Q1 | – | Sell |
-30,122
| Closed | -$1.6M | – | 204 |
|
|
2013
Q4 | $1.6M | Buy |
30,122
+159
| +0.5% | +$8.44K | 0.12% | 133 |
|
|
2013
Q3 | $1.4M | Sell |
29,963
-1,200
| -4% | -$56.2K | 0.12% | 130 |
|
|
2013
Q2 | $1.28M | Buy |
+31,163
| New | +$1.28M | 0.13% | 115 |
|